ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 59 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,847,759 | -60.8% | 269,746 | -40.6% | 0.01% | -65.9% |
| Q2 2023 | $4,712,242 | +2.1% | 454,411 | -20.3% | 0.04% | -6.8% |
| Q1 2023 | $4,613,264 | -28.9% | 570,243 | +38.3% | 0.04% | -18.5% |
| Q4 2022 | $6,492,749 | +3.1% | 412,238 | +3.0% | 0.05% | +1.9% |
| Q3 2022 | $6,300,000 | +3.4% | 400,160 | -8.3% | 0.05% | -10.2% |
| Q2 2022 | $6,090,000 | -25.3% | 436,260 | -7.7% | 0.06% | -19.2% |
| Q1 2022 | $8,150,000 | +14.3% | 472,760 | -3.6% | 0.07% | +12.3% |
| Q4 2021 | $7,131,000 | -22.7% | 490,460 | -4.4% | 0.06% | -31.6% |
| Q3 2021 | $9,231,000 | +106.7% | 512,875 | +101.6% | 0.10% | +102.1% |
| Q2 2021 | $4,466,000 | -51.8% | 254,344 | -30.8% | 0.05% | -58.4% |
| Q1 2021 | $9,258,000 | +366.4% | 367,392 | +19.7% | 0.11% | +318.5% |
| Q4 2020 | $1,985,000 | +209.7% | 306,900 | +23.2% | 0.03% | +125.0% |
| Q3 2020 | $641,000 | +0.8% | 249,200 | -36.5% | 0.01% | +33.3% |
| Q2 2020 | $636,000 | +2665.2% | 392,200 | +1661.4% | 0.01% | +800.0% |
| Q1 2020 | $23,000 | -97.6% | 22,266 | -65.7% | 0.00% | -97.6% |
| Q3 2018 | $944,000 | -27.4% | 65,000 | -0.2% | 0.04% | -40.0% |
| Q2 2018 | $1,300,000 | +61.7% | 65,100 | +42.1% | 0.07% | +16.7% |
| Q1 2018 | $804,000 | -25.9% | 45,828 | +14.6% | 0.06% | -46.4% |
| Q2 2017 | $1,085,000 | -24.7% | 40,000 | -17.1% | 0.11% | -22.2% |
| Q1 2017 | $1,440,000 | – | 48,277 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |